Kimberly-Clark beats preliminary Q3 estimates and keeps 2026 targets
Kimberly-Clark's preliminary third-quarter sales and adjusted profit beat analyst estimates, lifting shares 3% before the US open on Thursday.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Kimberly-Clark said on Thursday that preliminary third-quarter sales and profit came in above Wall Street forecasts. Steady demand for Huggies diapers and Kleenex tissues, along with cost-saving steps, supported the figures.
The Dallas-based company expects net sales of $4.13 billion, against an average analyst estimate of $4.10 billion compiled by LSEG. It projects adjusted earnings of $1.70 per share, versus $1.59 expected. Shares rose 3% in premarket trading.
The company reaffirmed its full-year 2026 targets after cutting its revenue and profit forecasts in the previous quarter, and it is set to complete the roughly $40 billion Kenvue acquisition by year-end. Separately, China said no formamide was found in the company's products, rejecting social media claims that Huggies diapers contained the substance, which had weighed on sales.
why it matters
The reaffirmed guidance and the China clearance ease some pressure on the stock ahead of the Kenvue closing. RBC analyst Nik Modi said the investigation update removes a meaningful overhang. The company also said the results open the calendar for close-related activities, including debt issuance, which investors will watch closely. Third-quarter results are due November 5.
tags
instruments
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗